BackBioNexus Gene Lab Overview

BioNexus Gene Lab Current Assets

Track BioNexus Gene Lab's current assets ($4.9M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$4.94M
↓ 22.51% YoYΔ $-1.44M vs prior year quarter

Peer trimmed avg / median

Loading

BioNexus Gene Lab Current Assets History

Loading

BioNexus Gene Lab vs. peers: Current Assets Comparison

Loading

BioNexus Gene Lab Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

BioNexus Gene Lab (BGLC) FAQ

BioNexus Gene Lab (BGLC) currently reports a current assets of $4.9M as of June 2026. That compares with $6.4M in the prior-year period — down 22.5% year over year. Use the charts on this page to explore BioNexus Gene Lab's current assets history and peer comparisons.

BioNexus Gene Lab's current assets decreased from $6.4M to $4.9M — a 22.5% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

BioNexus Gene Lab reported $4.9M in current assets as of June 2026. That compares with $6.4M in the prior-year period — down 22.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $4.9M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for BioNexus Gene Lab, and consider following BGLC for alerts when major investors trade the stock.